ALHC Earnings Prediction
The chart below shows how ALHC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ALHC sees a -2.92% change in stock price 10 days leading up to the earnings, and a -4.03% change 10 days following the report. On the earnings day itself, the stock moves by +2.43%. This data can give you a slight idea of what to expect for the next quarter's release.
ALHC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
692.43M
51.61%
1.64%
Gross Margin
10.30%
-11.82%
0.98%
Operating Margin
-2.75%
-54.70%
7.84%
Net Margin
-3.82%
-50.26%
8.52%
EPS
-0.14
-26.32%
7.69%
No Data Available
ALHC Earnings Analysis
Alignment Healthcare, Inc. Common Stock Corporation (ALHC.O) Earnings Conference Call
Positive
Health Plan Membership Growth: Health plan membership increased to 182,300 members, representing approximately 58% year-over-year growth.
Revenue Growth Analysis: Total revenue of $692 million grew approximately 52% year-over-year and 62% excluding ACO REACH.
Adjusted Gross Profit and EBITDA: Adjusted gross profit of $81 million produced a consolidated MBR of 88.4%, leading to adjusted EBITDA of positive $6 million in the quarter.
Health Plan Star Ratings: 98% of our health plan members are in plans rated 4-stars or above for 2025, marking the eighth consecutive year of our California HMO contract earning a 4-star or above rating.
Year-End Cash Projections: We expect year-end parent cash to be approximately the same or higher than Q3 parent cash due to the timing of intercompany transfers, which have no impact on total cash.
Negative
Record Revenue Growth: Total revenue of $692 million grew approximately 52% year-over-year and 62% growth excluding ACO REACH, marking our highest revenue growth quarter as a publicly traded company.
Adjusted Gross Profit Performance: Adjusted gross profit of $81 million was in line with the high-end of our guidance range, representing an MBR of 88.4%.
Strong Adjusted EBITDA Performance: Adjusted EBITDA of positive $6 million in the quarter, marking the second quarter in a row where both adjusted gross profit and adjusted EBITDA achieved the high-end of our guidance ranges, placing us on solid footing as we enter the final quarter of the year.
Membership Growth and Cost Control: Our Care Anywhere clinical model and real-time visibility into utilization enable us to manage care and control costs, while growing membership close to 60% year-over-year.
Year-End Cash Projections: We expect year-end parent cash to be approximately the same or higher than Q3 parent cash due to the timing of intercompany transfers, which have had no impact on total cash.
ALHC FAQs
How does ALHC typically perform around its earnings report dates?
Is Alignment Healthcare, Inc. (ALHC) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ALHC Earning Call Sentiment
Alignment Healthcare, Inc. (ALHC) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
ALHC.O
2.66%Positive
The earnings call highlights strong financial performance with record high revenue and positive adjusted EBITDA. Membership growth and raised guidance for 2024 are positive indicators. Despite some risks like regulatory changes and competitive pressures, the company has a clear strategy for growth and improvement. The Q&A session revealed analysts' positive sentiment towards the company's innovation and strategic investments. The lack of a shareholder return plan is a minor negative, but overall, the positive financial metrics and guidance outweigh the concerns, leading to a positive stock price prediction.
